Three methods to measure adherence to a medical nutrition therapy program in pregnant women with diabetes and its association with glycemic control

Autores: Balas Nakash Margie, Rodríguez Cano Ameyalli, Muñoz Manrique Cinthya, Vásquez Peña Paulina, Perichart Perera Otilia

Resumen

Introduction: The measurement of adherence to nutrition therapy is essential to evaluate if the outcomes are related to given recommendations. Material and methods: The aim of this study was to describe adherence to a Medical Nutrition Therapy Program in Mexican pregnant women with diabetes, using three different methods; and evaluate its association with glycemic control. Adherence was measured with a questionnaire (0-100%), women´s self-perception (0-100%) and energy intake adequacy using a multiple pass 24 hour recall (85-115% of recommendation). Women were randomly assigned to two different dietary strategies. Glycemic control was determined by capillary glucose self-monitoring. Results: Women analyzed in this study (n = 69) had an age range of 22-42 years; 47.8% had type 2 diabetes (DM2) and 52.2% had gestational diabetes (GDM). Energy intake adequacy was higher in women with GDM (41.9% vs. 37.7%, p = 0.001). Average adherence measured with the questionnaire was 55%; no differences were found by type of diabetes. Self-perception was higher in women with DM2 (84%) when compared to women with GDM (70%) (p = 0.039). No differences were found in the three methods by study group. Optimal glycemic control was observed in 50% of women; no association was found with adherence measured with any of the three methods studied. Conclusions: The observed differences in adherences suggest that it may be recommendable to combine different measurement methods and include social and psychological factors that affect behavioral change.

Palabras clave: Diabetes mellitus gestational diabetes adherence nutrition therapy glycemic control.

2010-10-07   |   1,218 visitas   |   Evalua este artículo 0 valoraciones

Vol. 62 Núm.3. Mayo-Junio 2010 Pags. 235-243 Rev Invest Clin 2010; 62(3-ENGLISH)